Garuda Therapeutics

Blood stem cell therapy is greatly limited by factors such as safety, durability, and collection timeliness. Garuda is developing the world’s first on-demand hematopoietic stem cell platform to offer individualized, curative therapies for patients. Generating self-renewing blood stem cells enables rapid and broad access for patients while easing dependency on donor and patient cells – especially critical where donor matches are nearly impossible to find.